These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Multimodality imaging in cardiac amyloidosis: a primer for cardiologists. Jurcuţ R; Onciul S; Adam R; Stan C; Coriu D; Rapezzi C; Popescu BA Eur Heart J Cardiovasc Imaging; 2020 Aug; 21(8):833-844. PubMed ID: 32393965 [TBL] [Abstract][Full Text] [Related]
8. Imaging in systemic amyloidosis. Sachchithanantham S; Wechalekar AD Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486 [TBL] [Abstract][Full Text] [Related]
9. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600 [TBL] [Abstract][Full Text] [Related]
10. Skeletal scintigraphy in patients with transthyretin-related amyloidosis. Kristen AV; Altland K; Katus HA Int J Cardiol; 2014 Feb; 171(2):e16-7. PubMed ID: 24360159 [No Abstract] [Full Text] [Related]
11. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906 [TBL] [Abstract][Full Text] [Related]
12. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. Dorbala S; Ando Y; Bokhari S; Dispenzieri A; Falk RH; Ferrari VA; Fontana M; Gheysens O; Gillmore JD; Glaudemans AWJM; Hanna MA; Hazenberg BPC; Kristen AV; Kwong RY; Maurer MS; Merlini G; Miller EJ; Moon JC; Murthy VL; Quarta CC; Rapezzi C; Ruberg FL; Shah SJ; Slart RHJA; Verberne HJ; Bourque JM J Nucl Cardiol; 2020 Apr; 27(2):659-673. PubMed ID: 31468377 [TBL] [Abstract][Full Text] [Related]
13. Advances in PET-Based Cardiac Amyloid Radiotracers. Gallegos C; Miller EJ Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600 [TBL] [Abstract][Full Text] [Related]
14. Nuclear imaging in cardiac amyloidosis. Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411 [TBL] [Abstract][Full Text] [Related]
15. Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns. Nappi C; Zampella E; Volpe F; De Risi M; Piscopo L; Ponsiglione A; Imbriaco M; Acampa W; Petretta M; Cuocolo A J Nucl Cardiol; 2020 Jun; 27(3):915-920. PubMed ID: 31845305 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the noninvasive strategies of cardiac amyloidosis. Zhao L; Fang Q Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493 [TBL] [Abstract][Full Text] [Related]
17. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis. Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773 [TBL] [Abstract][Full Text] [Related]
18. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. Treibel TA; Bandula S; Fontana M; White SK; Gilbertson JA; Herrey AS; Gillmore JD; Punwani S; Hawkins PN; Taylor SA; Moon JC J Cardiovasc Comput Tomogr; 2015; 9(6):585-92. PubMed ID: 26209459 [TBL] [Abstract][Full Text] [Related]
20. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]